Pancreatic Cancer Research

ResearcherUniversity of North Carolina at CharlotteActive in the last 2 years

Mubin Tarannum

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4440-1565; OpenAlex author ID A5090353523. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 3 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. From dual targeting to dynamic targeting: Rethinking CAR-NK cell therapy for pancreatic cancer. Co-author DOI 10.1016/j.omton.2026.201358↗
  2. Advanced Nanoengineering Approach for Target-Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine-Cisplatin Combination for Improved Therapeutic O… Co-author DOI 10.1002/smll.202104449↗
  3. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment. Co-author DOI 10.1016/j.addr.2022.114357↗
  4. Nanoparticle combination for precise stroma modulation and improved delivery for pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2022.05.019↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juan Luis Vivero-Escoto · 3 shared papers, 2022 · strength 0.72
  2. Pinku Mukherjee · 2 shared papers, 2022 · strength 0.39
  3. José A. Cancelas · 1 shared paper, 2026 · strength 0.39
  4. Kathrine S Rallis · 1 shared paper, 2026 · strength 0.39
  5. Didier Dréau · 1 shared paper, 2022 · strength 0.20
  6. Shan Yan · 1 shared paper, 2022 · strength 0.19
  7. Md Akram Hossain · 1 shared paper, 2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.